Prasco Laboratories, the Authorized Generics company, announced it has signed a supply agreement with Shionogi Inc. Under the terms of the agreement, Prasco will market and distribute Mefenamic Acid capsules, USP 250 mg, the Authorized Generic version of Ponstel. Prasco intends to begin shipping product immediately in the US under the Prasco label.

“With the introduction of the authorized generic of Shionogi’s Ponstel, Prasco continues to be the preferred partner for established brand companies to transcend their brands with our Authorized Generics,” said Prasco chief executive officer E. Thomas Arington. “We are pleased to have established this relationship with Shionogi Inc., a company that has been providing innovative medicines essential to people's health.”

Prasco is the leading Authorized Generics company having brought more Authorized Generics to market than any other company. Prasco Authorized Generics are identical to the NDA brand product. Prasco partners with established brand companies to bring their products to the generics marketplace as Authorized Generics, which offers alternatives for consumers and pharmacists.

Mefenamic Acid capsules are AB-rated, therapeutically equivalent and substitutable for the brand Ponstel.

Ponstel is a registered trademark of Shionogi Inc.

Prasco is the privately held healthcare company located in Mason, Ohio, that specializes in Authorized Generics. Prasco Authorized Generics provide patients with the identical brand drug experience at a price that competes with generics.